img

Global Long-Acting Injectables Market Research Report 2024

Published on: 2024-01-04 | No of Pages : 400 | Industry : Medical

Publisher : MRA | Format : PDF

Global Long-Acting Injectables Market Research Report 2024

Long-acting injectable (LAI) is a kind of pharmaceutical for treating patients with schizophrenia who relapse due to nonadherence to antipsychotic medication. Rather than the daily pill-taking required with oral antipsychotics, LAI antipsychotics are administered by injection at two to four weeks intervals.
According to MRAResearch’s new survey, global Long-Acting Injectables market is projected to reach US$ million in 2033, increasing from US$ million in 2022, with the CAGR of % during the period of 2023 to 2033. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Long-Acting Injectables market research.
Key companies engaged in the Long-Acting Injectables industry include Eli Lilly, Pfizer, GlaxoSmithKline, Johnson & Johnson, Lupin, Zogenix, DURECT and Medincel, etc. Among those companies, the top 3 players guaranteed % supply worldwide in 2022.
When refers to consumption region, % value of Long-Acting Injectables were sold to North America, Europe and Asia Pacific in 2022. Moreover, China, plays a key role in the whole Long-Acting Injectables market and estimated to attract more attentions from industry insiders and investors.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2033), aims to help readers to get a comprehensive understanding of global Long-Acting Injectables market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.



By Company


Eli Lilly
Pfizer
GlaxoSmithKline
Johnson & Johnson
Lupin
Zogenix
DURECT
Medincel
Segment by Type
Small and Middle Sized Molecule
Large Sized Molecule

Segment by Application


Schizophrenia
Other Psychotic Disorders
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
The Long-Acting Injectables report covers below items
Chapter 1Product Basic Information (Definition, Type and Application)
Chapter 2Global market size, regional market size. Market Opportunities and Challenges
Chapter 3Companies’ Competition Patterns
Chapter 4Product Type Analysis
Chapter 5Product Application Analysis
Chapter 6 to 10Country Level Value Analysis
Chapter 11Companies' Outline
Chapter 12Market Conclusions
Chapter 13Research Methodology and Data Source

Table of Content

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Long-Acting Injectables Market Size Growth Rate by Type: 2018 VS 2022 VS 2033
1.2.2 Small and Middle Sized Molecule
1.2.3 Large Sized Molecule
1.3 Market by Application
1.3.1 Global Long-Acting Injectables Market Growth by Application: 2018 VS 2022 VS 2033
1.3.2 Schizophrenia
1.3.3 Other Psychotic Disorders
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Long-Acting Injectables Market Perspective (2018-2033)
2.2 Long-Acting Injectables Growth Trends by Region
2.2.1 Global Long-Acting Injectables Market Size by Region: 2018 VS 2022 VS 2033
2.2.2 Long-Acting Injectables Historic Market Size by Region (2018-2023)
2.2.3 Long-Acting Injectables Forecasted Market Size by Region (2024-2033)
2.3 Long-Acting Injectables Market Dynamics
2.3.1 Long-Acting Injectables Industry Trends
2.3.2 Long-Acting Injectables Market Drivers
2.3.3 Long-Acting Injectables Market Challenges
2.3.4 Long-Acting Injectables Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Long-Acting Injectables Players by Revenue
3.1.1 Global Top Long-Acting Injectables Players by Revenue (2018-2023)
3.1.2 Global Long-Acting Injectables Revenue Market Share by Players (2018-2023)
3.2 Global Long-Acting Injectables Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Long-Acting Injectables Revenue
3.4 Global Long-Acting Injectables Market Concentration Ratio
3.4.1 Global Long-Acting Injectables Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Long-Acting Injectables Revenue in 2022
3.5 Long-Acting Injectables Key Players Head office and Area Served
3.6 Key Players Long-Acting Injectables Product Solution and Service
3.7 Date of Enter into Long-Acting Injectables Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Long-Acting Injectables Breakdown Data by Type
4.1 Global Long-Acting Injectables Historic Market Size by Type (2018-2023)
4.2 Global Long-Acting Injectables Forecasted Market Size by Type (2024-2033)
5 Long-Acting Injectables Breakdown Data by Application
5.1 Global Long-Acting Injectables Historic Market Size by Application (2018-2023)
5.2 Global Long-Acting Injectables Forecasted Market Size by Application (2024-2033)
6 North America
6.1 North America Long-Acting Injectables Market Size (2018-2033)
6.2 North America Long-Acting Injectables Market Growth Rate by Country: 2018 VS 2022 VS 2033
6.3 North America Long-Acting Injectables Market Size by Country (2018-2023)
6.4 North America Long-Acting Injectables Market Size by Country (2024-2033)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Long-Acting Injectables Market Size (2018-2033)
7.2 Europe Long-Acting Injectables Market Growth Rate by Country: 2018 VS 2022 VS 2033
7.3 Europe Long-Acting Injectables Market Size by Country (2018-2023)
7.4 Europe Long-Acting Injectables Market Size by Country (2024-2033)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Long-Acting Injectables Market Size (2018-2033)
8.2 Asia-Pacific Long-Acting Injectables Market Growth Rate by Region: 2018 VS 2022 VS 2033
8.3 Asia-Pacific Long-Acting Injectables Market Size by Region (2018-2023)
8.4 Asia-Pacific Long-Acting Injectables Market Size by Region (2024-2033)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Long-Acting Injectables Market Size (2018-2033)
9.2 Latin America Long-Acting Injectables Market Growth Rate by Country: 2018 VS 2022 VS 2033
9.3 Latin America Long-Acting Injectables Market Size by Country (2018-2023)
9.4 Latin America Long-Acting Injectables Market Size by Country (2024-2033)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Long-Acting Injectables Market Size (2018-2033)
10.2 Middle East & Africa Long-Acting Injectables Market Growth Rate by Country: 2018 VS 2022 VS 2033
10.3 Middle East & Africa Long-Acting Injectables Market Size by Country (2018-2023)
10.4 Middle East & Africa Long-Acting Injectables Market Size by Country (2024-2033)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Eli Lilly
11.1.1 Eli Lilly Company Detail
11.1.2 Eli Lilly Business Overview
11.1.3 Eli Lilly Long-Acting Injectables Introduction
11.1.4 Eli Lilly Revenue in Long-Acting Injectables Business (2018-2023)
11.1.5 Eli Lilly Recent Development
11.2 Pfizer
11.2.1 Pfizer Company Detail
11.2.2 Pfizer Business Overview
11.2.3 Pfizer Long-Acting Injectables Introduction
11.2.4 Pfizer Revenue in Long-Acting Injectables Business (2018-2023)
11.2.5 Pfizer Recent Development
11.3 GlaxoSmithKline
11.3.1 GlaxoSmithKline Company Detail
11.3.2 GlaxoSmithKline Business Overview
11.3.3 GlaxoSmithKline Long-Acting Injectables Introduction
11.3.4 GlaxoSmithKline Revenue in Long-Acting Injectables Business (2018-2023)
11.3.5 GlaxoSmithKline Recent Development
11.4 Johnson & Johnson
11.4.1 Johnson & Johnson Company Detail
11.4.2 Johnson & Johnson Business Overview
11.4.3 Johnson & Johnson Long-Acting Injectables Introduction
11.4.4 Johnson & Johnson Revenue in Long-Acting Injectables Business (2018-2023)
11.4.5 Johnson & Johnson Recent Development
11.5 Lupin
11.5.1 Lupin Company Detail
11.5.2 Lupin Business Overview
11.5.3 Lupin Long-Acting Injectables Introduction
11.5.4 Lupin Revenue in Long-Acting Injectables Business (2018-2023)
11.5.5 Lupin Recent Development
11.6 Zogenix
11.6.1 Zogenix Company Detail
11.6.2 Zogenix Business Overview
11.6.3 Zogenix Long-Acting Injectables Introduction
11.6.4 Zogenix Revenue in Long-Acting Injectables Business (2018-2023)
11.6.5 Zogenix Recent Development
11.7 DURECT
11.7.1 DURECT Company Detail
11.7.2 DURECT Business Overview
11.7.3 DURECT Long-Acting Injectables Introduction
11.7.4 DURECT Revenue in Long-Acting Injectables Business (2018-2023)
11.7.5 DURECT Recent Development
11.8 Medincel
11.8.1 Medincel Company Detail
11.8.2 Medincel Business Overview
11.8.3 Medincel Long-Acting Injectables Introduction
11.8.4 Medincel Revenue in Long-Acting Injectables Business (2018-2023)
11.8.5 Medincel Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Figure

List of Tables
Table 1. Global Long-Acting Injectables Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2033
Table 2. Key Players of Small and Middle Sized Molecule
Table 3. Key Players of Large Sized Molecule
Table 4. Global Long-Acting Injectables Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2033
Table 5. Global Long-Acting Injectables Market Size by Region (US$ Million): 2018 VS 2022 VS 2033
Table 6. Global Long-Acting Injectables Market Size by Region (2018-2023) & (US$ Million)
Table 7. Global Long-Acting Injectables Market Share by Region (2018-2023)
Table 8. Global Long-Acting Injectables Forecasted Market Size by Region (2024-2033) & (US$ Million)
Table 9. Global Long-Acting Injectables Market Share by Region (2024-2033)
Table 10. Long-Acting Injectables Market Trends
Table 11. Long-Acting Injectables Market Drivers
Table 12. Long-Acting Injectables Market Challenges
Table 13. Long-Acting Injectables Market Restraints
Table 14. Global Long-Acting Injectables Revenue by Players (2018-2023) & (US$ Million)
Table 15. Global Long-Acting Injectables Market Share by Players (2018-2023)
Table 16. Global Top Long-Acting Injectables Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Long-Acting Injectables as of 2022)
Table 17. Ranking of Global Top Long-Acting Injectables Companies by Revenue (US$ Million) in 2022
Table 18. Global 5 Largest Players Market Share by Long-Acting Injectables Revenue (CR5 and HHI) & (2018-2023)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Long-Acting Injectables Product Solution and Service
Table 21. Date of Enter into Long-Acting Injectables Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Long-Acting Injectables Market Size by Type (2018-2023) & (US$ Million)
Table 24. Global Long-Acting Injectables Revenue Market Share by Type (2018-2023)
Table 25. Global Long-Acting Injectables Forecasted Market Size by Type (2024-2033) & (US$ Million)
Table 26. Global Long-Acting Injectables Revenue Market Share by Type (2024-2033)
Table 27. Global Long-Acting Injectables Market Size by Application (2018-2023) & (US$ Million)
Table 28. Global Long-Acting Injectables Revenue Market Share by Application (2018-2023)
Table 29. Global Long-Acting Injectables Forecasted Market Size by Application (2024-2033) & (US$ Million)
Table 30. Global Long-Acting Injectables Revenue Market Share by Application (2024-2033)
Table 31. North America Long-Acting Injectables Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 32. North America Long-Acting Injectables Market Size by Country (2018-2023) & (US$ Million)
Table 33. North America Long-Acting Injectables Market Size by Country (2024-2033) & (US$ Million)
Table 34. Europe Long-Acting Injectables Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 35. Europe Long-Acting Injectables Market Size by Country (2018-2023) & (US$ Million)
Table 36. Europe Long-Acting Injectables Market Size by Country (2024-2033) & (US$ Million)
Table 37. Asia-Pacific Long-Acting Injectables Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2033
Table 38. Asia-Pacific Long-Acting Injectables Market Size by Region (2018-2023) & (US$ Million)
Table 39. Asia-Pacific Long-Acting Injectables Market Size by Region (2024-2033) & (US$ Million)
Table 40. Latin America Long-Acting Injectables Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 41. Latin America Long-Acting Injectables Market Size by Country (2018-2023) & (US$ Million)
Table 42. Latin America Long-Acting Injectables Market Size by Country (2024-2033) & (US$ Million)
Table 43. Middle East & Africa Long-Acting Injectables Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 44. Middle East & Africa Long-Acting Injectables Market Size by Country (2018-2023) & (US$ Million)
Table 45. Middle East & Africa Long-Acting Injectables Market Size by Country (2024-2033) & (US$ Million)
Table 46. Eli Lilly Company Detail
Table 47. Eli Lilly Business Overview
Table 48. Eli Lilly Long-Acting Injectables Product
Table 49. Eli Lilly Revenue in Long-Acting Injectables Business (2018-2023) & (US$ Million)
Table 50. Eli Lilly Recent Development
Table 51. Pfizer Company Detail
Table 52. Pfizer Business Overview
Table 53. Pfizer Long-Acting Injectables Product
Table 54. Pfizer Revenue in Long-Acting Injectables Business (2018-2023) & (US$ Million)
Table 55. Pfizer Recent Development
Table 56. GlaxoSmithKline Company Detail
Table 57. GlaxoSmithKline Business Overview
Table 58. GlaxoSmithKline Long-Acting Injectables Product
Table 59. GlaxoSmithKline Revenue in Long-Acting Injectables Business (2018-2023) & (US$ Million)
Table 60. GlaxoSmithKline Recent Development
Table 61. Johnson & Johnson Company Detail
Table 62. Johnson & Johnson Business Overview
Table 63. Johnson & Johnson Long-Acting Injectables Product
Table 64. Johnson & Johnson Revenue in Long-Acting Injectables Business (2018-2023) & (US$ Million)
Table 65. Johnson & Johnson Recent Development
Table 66. Lupin Company Detail
Table 67. Lupin Business Overview
Table 68. Lupin Long-Acting Injectables Product
Table 69. Lupin Revenue in Long-Acting Injectables Business (2018-2023) & (US$ Million)
Table 70. Lupin Recent Development
Table 71. Zogenix Company Detail
Table 72. Zogenix Business Overview
Table 73. Zogenix Long-Acting Injectables Product
Table 74. Zogenix Revenue in Long-Acting Injectables Business (2018-2023) & (US$ Million)
Table 75. Zogenix Recent Development
Table 76. DURECT Company Detail
Table 77. DURECT Business Overview
Table 78. DURECT Long-Acting Injectables Product
Table 79. DURECT Revenue in Long-Acting Injectables Business (2018-2023) & (US$ Million)
Table 80. DURECT Recent Development
Table 81. Medincel Company Detail
Table 82. Medincel Business Overview
Table 83. Medincel Long-Acting Injectables Product
Table 84. Medincel Revenue in Long-Acting Injectables Business (2018-2023) & (US$ Million)
Table 85. Medincel Recent Development
Table 86. Research Programs/Design for This Report
Table 87. Key Data Information from Secondary Sources
Table 88. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Long-Acting Injectables Market Size Comparison by Type (2023-2033) & (US$ Million)
Figure 2. Global Long-Acting Injectables Market Share by Type: 2022 VS 2033
Figure 3. Small and Middle Sized Molecule Features
Figure 4. Large Sized Molecule Features
Figure 5. Global Long-Acting Injectables Market Size Comparison by Application (2023-2033) & (US$ Million)
Figure 6. Global Long-Acting Injectables Market Share by Application: 2022 VS 2033
Figure 7. Schizophrenia Case Studies
Figure 8. Other Psychotic Disorders Case Studies
Figure 9. Long-Acting Injectables Report Years Considered
Figure 10. Global Long-Acting Injectables Market Size (US$ Million), Year-over-Year: 2018-2033
Figure 11. Global Long-Acting Injectables Market Size, (US$ Million), 2018 VS 2022 VS 2033
Figure 12. Global Long-Acting Injectables Market Share by Region: 2022 VS 2033
Figure 13. Global Long-Acting Injectables Market Share by Players in 2022
Figure 14. Global Top Long-Acting Injectables Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Long-Acting Injectables as of 2022)
Figure 15. The Top 10 and 5 Players Market Share by Long-Acting Injectables Revenue in 2022
Figure 16. North America Long-Acting Injectables Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 17. North America Long-Acting Injectables Market Share by Country (2018-2033)
Figure 18. United States Long-Acting Injectables Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 19. Canada Long-Acting Injectables Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 20. Europe Long-Acting Injectables Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 21. Europe Long-Acting Injectables Market Share by Country (2018-2033)
Figure 22. Germany Long-Acting Injectables Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 23. France Long-Acting Injectables Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 24. U.K. Long-Acting Injectables Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 25. Italy Long-Acting Injectables Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 26. Russia Long-Acting Injectables Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 27. Nordic Countries Long-Acting Injectables Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 28. Asia-Pacific Long-Acting Injectables Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 29. Asia-Pacific Long-Acting Injectables Market Share by Region (2018-2033)
Figure 30. China Long-Acting Injectables Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 31. Japan Long-Acting Injectables Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 32. South Korea Long-Acting Injectables Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 33. Southeast Asia Long-Acting Injectables Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 34. India Long-Acting Injectables Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 35. Australia Long-Acting Injectables Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 36. Latin America Long-Acting Injectables Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 37. Latin America Long-Acting Injectables Market Share by Country (2018-2033)
Figure 38. Mexico Long-Acting Injectables Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 39. Brazil Long-Acting Injectables Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 40. Middle East & Africa Long-Acting Injectables Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 41. Middle East & Africa Long-Acting Injectables Market Share by Country (2018-2033)
Figure 42. Turkey Long-Acting Injectables Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 43. Saudi Arabia Long-Acting Injectables Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 44. Eli Lilly Revenue Growth Rate in Long-Acting Injectables Business (2018-2023)
Figure 45. Pfizer Revenue Growth Rate in Long-Acting Injectables Business (2018-2023)
Figure 46. GlaxoSmithKline Revenue Growth Rate in Long-Acting Injectables Business (2018-2023)
Figure 47. Johnson & Johnson Revenue Growth Rate in Long-Acting Injectables Business (2018-2023)
Figure 48. Lupin Revenue Growth Rate in Long-Acting Injectables Business (2018-2023)
Figure 49. Zogenix Revenue Growth Rate in Long-Acting Injectables Business (2018-2023)
Figure 50. DURECT Revenue Growth Rate in Long-Acting Injectables Business (2018-2023)
Figure 51. Medincel Revenue Growth Rate in Long-Acting Injectables Business (2018-2023)
Figure 52. Bottom-up and Top-down Approaches for This Report
Figure 53. Data Triangulation
Figure 54. Key Executives Interviewed

Select User License

$4200 Single Licence
$6000 Enterprise Licence
$9100 Corporate Licence
Note : All prices in USD

FAQ'S

User License?

For a single, multi and corporate client license, the report will be available in PDF format. Sample report would be given you in excel format. For more questions please contact:

sales@mraccuracyreports.com

Within 24 to 48 hrs.

You can contact Sales team (sales@mraccuracyreports.com) and they will direct you on email

You can order a report by selecting payment methods, which is bank wire or online payment through any Debit/Credit card, Razor pay or PayPal.

Discounts are available.

Hard Copy

Email

Top Industries